Zhejiang Ausun Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 381.35 million compared to CNY 285.28 million a year ago. Revenue was CNY 381.36 million compared to CNY 285.65 million a year ago.

Net income was CNY 123.02 million compared to CNY 82.69 million a year ago. Basic earnings per share from continuing operations was CNY 0.2214 compared to CNY 0.15 a year ago. Diluted earnings per share from continuing operations was CNY 0.2214 compared to CNY 0.15 a year ago.